VERTEX PHARMACEUTICALS INC / MA (VRTX) Options Risk Score

Run a full VRTX options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on VERTEX PHARMACEUTICALS INC / MA (VRTX) right now?

VERTEX PHARMACEUTICALS INC / MA (VRTX) currently scores 86 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. That score is driven by an upcoming earnings report, 2 recent news items, 3 recent SEC events and 33 clinical-trial catalysts falling inside the 4-week window. On TickerRisk's scale 70 and above is HIGH, so a known event is scheduled inside this window — selling premium on VRTX here is a bet on that event rather than on time decay. The score measures scheduled event exposure, not which way the stock will move.

VRTX shows an IV Rank of 65, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 39%. IV Rank is the most useful figure for deciding whether to sell or buy premium on VRTX.

VRTX is scheduled to report earnings on 2026-11-02, which falls inside a typical monthly options expiry — expect elevated implied volatility into the event and an IV crush afterward.

VERTEX PHARMACEUTICALS INC / MA (VRTX) current implied volatility and IV Rank

VERTEX PHARMACEUTICALS INC / MA (VRTX) currently has an IV Rank of 65 with implied volatility around 39%, alongside a TickerRisk options-risk score of 86/100. That's moderate — options are fairly priced versus the past year, so there's no strong volatility edge in either direction right now; trade the direction, not the vol.

For what this number does and does not tell you about VRTX's options, see IV Rank explained.

VERTEX PHARMACEUTICALS INC / MA (VRTX) next earnings date — 2026-11-02

VERTEX PHARMACEUTICALS INC / MA (VRTX) is scheduled to report on 2026-11-02 — about 12 days away, so a standard expiry would carry straight through it. VRTX's IV Rank is currently 65. Implied volatility tends to build into the date and drop sharply once results are public. If the premium on VRTX looks unusually generous right now, this is the most likely reason.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer